Yes, the official word is going to be that he lives there whether he actually does or not according to whatever strict definition might apply.
I think that's a minor point compared to what appears to be limited resources being applied to setting this up - it still smacks of a DIY "on the cheap" effort. I always find myself returning to the IP issue which is at the heart of many biotechs - the monetization of some proprietary research at MIT or wherever. Yes, sub-40nm liposomes look promising; Yes, the speculation around ceramides looks interesting (as so many other things have at the embryonic stage), but that doesn't mean this ticker is going to be built on a solid, defend-able collection of related IP until there's some evidence of something more than what might be a cobbled-together company looking to play in that space without a >coughcough< compelling competitive advantage.
As for the copy-and-paste word salad in the website, big deal - there's not anything specific to back it up and some of the snake-oil phraseology doesn't help at all. Talking about "negotiating agreements," etc. is a big "meh." No one who hasn't done that should be involved at a senior level. And where are they? What are they specifically about, even if the detail is understandable absent. There's no directly relationships to the published research efforts that I could discern.
All stuff one has to worry about in any investment - it's not like the big established players don't whiff often when they're at bat...
So bottom line, something could indeed come of it - there's certainly some activity that reflects the principals' ownership of the ticker. But a deux-ex-machina that blows through a pink-sheet filing completion to an uplist with a solid portfolio of groundbreaking biotech IP? Maayyybbe? CCA redux? An effort that gets abandoned? A shell that -as mentioned- might be set up enough to sell to someone to reverse-merge into? I mean, it's not a dog-faced cryptocurrency, but there might be some potential there.
Look up EPIC electronic medical record software. Microsoft. 3Com when it fooled around with something called a Palm Organizer out of U.S. Robotics. All kind of half-assed in the beginning, so who knows?
News 
Market Data 
Discover 
AI
